Steven Cohen's KZIA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 200,300 shares of Kazia Therapeutics Limited (KZIA) worth $2.3 M, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in KZIA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 300 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Kazia Therapeutics Limited (KZIA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kazia Therapeutics Limited (KZIA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +300 | Add 0.15% | 200,300 | $11.50 |
| Q4 2025 | +200,000 | New Buy | 200,000 | $6.89 |
Steven Cohen's Kazia Therapeutics Limited Investment FAQs
Steven Cohen first purchased Kazia Therapeutics Limited (KZIA) in Q4 2025, acquiring 200,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Kazia Therapeutics Limited (KZIA) for 3 quarters since Q4 2025.
Steven Cohen's largest addition to Kazia Therapeutics Limited (KZIA) was in Q4 2025, adding 200,000 shares worth $1.38 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 200,300 shares of Kazia Therapeutics Limited (KZIA), valued at approximately $2.3 M.
As of the Q2 2026 filing, Kazia Therapeutics Limited (KZIA) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Kazia Therapeutics Limited (KZIA) was 200,300 shares, as reported at the end of Q2 2026.